ABG
SGHT icon

Ally Bridge Group’s Sight Sciences SGHT Stock Holding History

Ally Bridge Group’s Portfolio SGHT Stock Details SGHT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-314,804
Closed -$3.64M – 25
2022
Q1 		$3.64M Sell
314,804
-27,500
-8% -$423K 2.7% 19
2021
Q4 		$6.01M Hold
342,304
– – 2.1% 21
2021
Q3 		$7.77M Buy
+342,304
New +$11.3M 2.28% 21

Other funds holding SGHT

DCP
D1 Capital Partners New York $11.2B AUM 15.78% 1-Year Est. Return
KL
KCK Ltd Hamilton, Bermuda $15.1M AUM 30.14% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return

Ally Bridge Group's SGHT Position: Q2 2022 in Review

Ally Bridge Group sold out of Sight Sciences (SGHT) in Q2 2022, closing a stake of 314,804 shares — an estimated $3.64M sold.

Ally Bridge Group first reported a position in SGHT in Q3 2021 and held it in 3 quarters. The position peaked at $7.77M in Q3 2021. 68 funds tracked by Wall St. Rank hold SGHT as of Q2 2022.

  • Ally Bridge Group reported no remaining Sight Sciences position as of Q2 2022 after selling out during the quarter.
  • Ally Bridge Group sold 314,804 Sight Sciences shares in Q2 2022, an estimated $3.64M.
  • Ally Bridge Group first reported a position in Sight Sciences in Q3 2021 and held it in 3 quarters.
  • Ally Bridge Group's Sight Sciences position peaked at $7.77M in Q3 2021.
  • 68 funds tracked by Wall St. Rank held Sight Sciences as of Q2 2022.

Based on Ally Bridge Group's 13F filing for Q2 2022, filed 15 Aug 2022.